Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine
NCT05835635
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Patient Satisfaction
Patient Preference
Quality of Life
Acceptability of Health Care
Sponsor
Pontificia Universidad Catolica de Chile
Collaborators
[object Object]